TISSIUM’s COAPTIUM® CONNECT System, a novel sutureless solution for peripheral nerve repair, has shown promising results in a clinical study presented at the IFSSH Congress. The study demonstrated 100% procedural success in repairing digital nerve injuries, with all patients regaining full digit function and reporting no pain at one year. This innovative approach addresses the limitations of traditional suture-based nerve repair, which can cause further trauma and inconsistent recovery.

This development is particularly important for patients suffering from peripheral nerve injuries, offering a potentially less invasive and more effective treatment option. Successful nerve repair is crucial for restoring function and quality of life, as these injuries can lead to significant impairments. The complete recovery and lack of pain reported in the study suggest a potential for substantial improvement in patient outcomes compared to current standards of care.

The prospective, single-arm study involved 12 patients with digital nerve injuries, 10 of whom completed the one-year follow-up. The COAPTIUM® CONNECT System uses a bioresorbable, light-activated polymer and a protective coaptation chamber, eliminating the need for sutures. No device-related complications or neuromas were observed during the study period. The system’s atraumatic nature is a significant advantage, as it preserves nerve integrity and promotes healing.

This positive clinical data signifies a potential paradigm shift in nerve repair. The COAPTIUM® CONNECT System could become a preferred method for surgeons, offering a simpler, less traumatic, and potentially more effective approach. Further research and broader applications of the technology are anticipated, potentially expanding its use to various types of nerve injuries and improving patient care across multiple surgical specialties.

Source link: https://www.globenewswire.com/news-release/2025/04/02/3054587/0/en/TISSIUM-Announces-Clinical-Results-of-COAPTIUM-CONNECT-System-for-Atraumatic-Sutureless-Nerve-Repair.html

+ posts

Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.